Research Site US-97202-001009 — Riverdale, Georgia

Research Site US-97202-001009 is a clinical research site located in Riverdale, Georgia, United States 30274.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site US-97202-001009 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM).

Sponsors: Metsera, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site US-97202-001009?

Research Site US-97202-001009 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site US-97202-001009 conducted?

Research Site US-97202-001009 has 1 clinical trials on record, with 1 currently active. Their work covers Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM).

Is Research Site US-97202-001009 accredited by Crixeo Health?

Research Site US-97202-001009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site US-97202-001009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.